BCL2 and cancer: As the expression of individual anti-apoptotic BCL-2 family members varies substantially between different leukocyte subtypes and their activation statuses, BH3-mimetics may also represent a powerful tool to target specific cell types in diseases other than cancer, for example in immune disorders.